Updated August 11, 2026 · AltIndex alt-data view going into the print
AltIndex AI Score on Trevi Therapeutics is 63 — signals are mixed heading into the print. Underlying trend: 3 tracked signals showing mixed direction over the last 3 months.
Trevi Therapeutics (TRVI) is trading at $17.80, up 16.6% over the last 3 months (from $15.27 three months ago).
Trends across the last 3 months — the run-up to Trevi Therapeutics ’s next earnings print.
| Signal | Current | 3-month change |
|---|---|---|
| Job postings | 0 | No 3-month baseline |
| LinkedIn headcount | 48 | ↑ +9.1% |
| Web traffic | 3,998 | ↓ -9.4% |
| Employee business outlook | 100% Strongly positive | → flat |
Full daily-resolution trend charts on every signal are on the TRVI ticker page.
AltIndex stock alerts fire when alt-data on TRVI breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.
Sign up to AltIndex →Other companies in the AltIndex universe reporting earnings in the next 2 weeks, sorted by AI Score.
Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Trevi Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.
Sign up to AltIndex → Log in